Dexketoprofen and Ibuprofen in Long Bone Fractures

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to compare the efficacy of ibuprofen and dexketoprofen, two common analgesic drugs used in pain control in patients with long bone fractures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture

NCT00240396

Tibia Fracture Femur Fracture Humerus Fracture

WITHDRAWN NA

Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam

NCT02160236

Postoperative Pain

UNKNOWN PHASE4

NSAIDS vs Opioids in Tibial Fractures

NCT05332314

Trauma

UNKNOWN PHASE4

Comparing Efficacy of Intravenous Dexmedetomidine and Lidocaine on Postoperative Analgesia in Patients Undergoing Fracture Hip Surgery

NCT06865469

Fracture Hip Surgery

NOT_YET_RECRUITING PHASE3

Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type

NCT01119209

Hip Fracture of Intertrochanteric Type

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Long bone fractures are the fractures of long bones (tibia, femur, humerus) in the human body. Such fractures usually occur as a result of trauma and are manifested by symptoms such as pain, swelling, bruising and limitation of movement. Effective control of pain can help the patient relax and facilitate the healing process. Ibuprofen and dexketoprofen, which belong to the class of non-steroidal anti-inflammatory drugs (NSAID), are among the analgesics commonly used in the pain management of all fractures. These drugs are thought to be able to relieve pain, reduce inflammation, and help patients move. However, each patient's individual response and tolerance may differ, so the efficacy and side effects of each drug may vary from patient to patient. This makes it difficult to determine which analgesic is more effective and safe in clinical practice. The fact that it is a subject that has not been done much in the literature has led us to do this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Bone Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ibuprofen

ibuprofen intravenous 800 mg

Group Type EXPERIMENTAL

Ibuprofen 800 mg

Intervention Type DRUG

Ibuprofen 800 Mg İv

dexketoprofen

dexketoprofen intravenous 50 mg

Group Type EXPERIMENTAL

Dexketoprofen

Intervention Type DRUG

Dexketoprofen 50 Mg İV

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ibuprofen 800 mg

Ibuprofen 800 Mg İv

Intervention Type DRUG

Dexketoprofen

Dexketoprofen 50 Mg İV

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* over 18 years
* Patients under 80 years of age
* Patients who agreed to participate in the study
* One of the tibia, femur and humerus bones is broken
* Patients with a VAS score of 50 and above
* Patients with no other injuries requiring emergency surgery
* Previously known adverse reactions to the active ingredient of the drugs to be used patients with no history
* Conscious patients
* Oriented cooperative patients

Exclusion Criteria

* Patients under the age of 18 and over the age of 80
* Patients who did not agree to participate in the study
* Patients with vital signs outside the normal limits
* Patients with a history of adverse reactions to known NSAIDs
* Those who cannot determine the severity of pain on the VAS
* Patients with a VAS Score of 50 mm or less
* Those with other orthopedic injuries pregnant women
* Those with advanced systemic disease
* Those with malignancy
* Those with chronic liver and kidney disease
* Those who use neuro-psychiatric drugs with sedative and analgesic effects
* Those with a history of psychological and neurological diseases
* Patients using analgesics 8 hours before the examination

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No